PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19082914-10	2009	RANKL mRNA expression induced by 1,25-dihydroxyvitamin D(3) plus prostaglandin E(2) in osteoblasts was not affected by docetaxel even at 10(-6) M. Docetaxel at 10(-6) M, but not at 10(-8) M, inhibited pit-forming activity of osteoclasts cultured on dentine.	1,25-dihydroxyvitamin D	33-56	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	0-5	
12387822-6	2002	In cocultures of E1 cells and mouse bone marrow cells, histamine stimulated osteoclastogenesis in the presence of 1,25-dihydroxyvitamin D(3) and this effect was blocked by preincubation with neutralizing antibody against ODF/RANKL.	1,25-dihydroxyvitamin D	114-137	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	221-224	
20941510-1	2010	1alpha,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] induces osteoclast formation via induction of receptor activator of NF-kappaB ligand (RANKL, also called TNF-related activation-induced cytokine: TRANCE) in osteoblasts.	1,25-dihydroxyvitamin D	0-28	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	96-134	
20941510-1	2010	1alpha,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] induces osteoclast formation via induction of receptor activator of NF-kappaB ligand (RANKL, also called TNF-related activation-induced cytokine: TRANCE) in osteoblasts.	1,25-dihydroxyvitamin D	0-28	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	136-141	
19819969-8	2009	The expression of RANKL and OPG in chondrocytes was regulated by several osteotropic factors including 1,25-dihydroxyvitamin D(3), PTHrP, IL-1alpha, and TNF-alpha.	1,25-dihydroxyvitamin D	103-126	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	18-23	
19057837-9	2009	In SDM, in the presence of recombinant RANKL, RAW 264.7 cells readily differentiated into tartrate resistant acid phosphatase (TRAP) positive multinucleated osteoclast-like cells, a process that was enhanced with the addition of 1alpha,25-dihydroxyvitamin D(3) (1,25D).	1,25-dihydroxyvitamin D	229-257	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	39-44	
17932217-2	2008	We have previously shown that PTH and 1,25-dihydroxyvitamin D(3) control murine RANKL gene expression in vitro, in part, via an evolutionarily conserved transcriptional enhancer, designated the distal control region (DCR), located 76 kb upstream from the transcription start site.	1,25-dihydroxyvitamin D	38-61	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	80-85	
17932217-4	2008	Deletion of the DCR reduced PTH and 1,25-dihydroxyvitamin D(3) stimulation of RANKL mRNA and osteoclast formation in primary bone marrow cultures as well as stimulation of RANKL mRNA in bone.	1,25-dihydroxyvitamin D	36-59	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	78-83	
17182555-7	2007	The serum level of RANKL in OPG(-/-) mice was increased by ovariectomy or administration of 1alpha,25-dihydroxyvitamin D(3).	1,25-dihydroxyvitamin D	92-120	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	19-24	
11250921-4	2001	In the bone marrow stromal cell line ST2 and preosteoblastic cell line MC3T3-E1, all three RANKL isoforms were detected, but the expression of RANKL 2 was preferentially suppressed by treatment with 1alpha,25-dihydroxyvitamin D(3) and dexamethasone.	1,25-dihydroxyvitamin D	199-227	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	91-96	
11250921-4	2001	In the bone marrow stromal cell line ST2 and preosteoblastic cell line MC3T3-E1, all three RANKL isoforms were detected, but the expression of RANKL 2 was preferentially suppressed by treatment with 1alpha,25-dihydroxyvitamin D(3) and dexamethasone.	1,25-dihydroxyvitamin D	199-227	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	143-148